Agfa's Open Letter to De Tijd, Mediafin and De Persgroep

Agfa HealthCareDear Sir, I noted that De Tijd, and Bert Broens in particular, is continuing without abatement its 'damage Agfa-Gevaert' campaign. In recent months, we have noticed that this journalist continuously reports on Agfa-Gevaert in a one-sided negative manner and that he doesn't hesitate to publish inaccurate information.

The most striking examples were the articles published just before the General Meeting of Shareholders held in April. In these articles, he claimed that a number of important Agfa-Gevaert shareholders would vote against certain agenda items. When we checked this with our shareholders, the information turned out to be completely false. Templeton, our main shareholder, even felt forced to issue a press release to deny the content of the articles. In this case it is clear that even the most elementary rules of objective journalism were not observed.

Another example is a series of articles with completely false information about a possible operation involving Agfa Graphics. Insiders in the business know that this campaign was inspired by the management of Punch. I leave it to you to decide if this is ethically acceptable.

More recently, the campaign is aimed at Agfa HealthCare. This business group's important successes, such as the huge contract signed with the Paris hospitals, were minimized. In today's article some details were used to create a completely negative image.

It is obvious that we are not able to win every single contract. If that would be the case, we would hold a monopoly. Furthermore, it is only normal that occasionally a colleague leaves the company. It seems to me that this shouldn't be a reason for this type of negative coverage either.

Regarding this article, not a single contact was made with our company in order to at least check the accuracy of the information or to obtain additional information.

Again, I leave it to you to judge the quality of this kind of journalism.

I personally have put all means of communication at Bert Broens' disposal, my private mobile phone number included. I believe I can't do more than that.

Agfa-Gevaert is one of the few Belgian companies with very important global market shares in almost all of its activities. This goes for both our graphic and our healthcare business. Our competitors are therefore only too anxious to translate and spread this kind of articles amongst our customers.

Why a newspaper, which is presenting itself as the newspaper for the entrepreneurs in Flanders, is leading such a damaging campaign, goes beyond my comprehension.

It will therefore come to you as no surprise that I will demand - as a right to reply - the publication of a text from my hand, of comparable length in De Tijd.

In my opinion, this is the strict minimum that can be done to somewhat limit the significant economic damage created by this campaign.

Jo Cornu
CEO Agfa-Gevaert

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,283 million Euro in 2007.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales. For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...